NASDAQ:BKYI BIO-key International (BKYI) Stock Price, News & Analysis → Don't Miss Out on the New Untapped Potential Stock Report for 2024 (From Market Crux) (Ad) Free BKYI Stock Alerts $1.86 +0.16 (+9.41%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$1.70▼$1.8950-Day Range$1.50▼$1.9752-Week Range$1.48▼$14.40Volume12,908 shsAverage Volume9,881 shsMarket Capitalization$3.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Get BIO-key International alerts: Email Address Ad Crypto 101 Media$16T Crypto Plot From Elon MuskReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About BIO-key International Stock (NASDAQ:BKYI)BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.Read More BKYI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BKYI Stock News HeadlinesJune 13 at 10:30 AM | globenewswire.comIdentity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ETMay 31, 2024 | globenewswire.comIdentity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ETMay 24, 2024 | globenewswire.comBIO-key International, Inc. Receives Notice of Non-Compliance from NasdaqMay 16, 2024 | globenewswire.comBIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next WeekMay 11, 2024 | morningstar.comBIO-key International Inc BKYIMay 7, 2024 | globenewswire.comBIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024April 24, 2024 | investing.comBIO-key faces Nasdaq non-compliance noticeApril 22, 2024 | globenewswire.comBIO-key International, Inc. Receives Notice of Non-Compliance from NasdaqApril 17, 2024 | morningstar.comBIO-key International IncApril 9, 2024 | finance.yahoo.comSwitzerland’s Canton of Ticino Implements BIO-key’s Multi-Factor Authentication Solution in its Information Systems CenterApril 9, 2024 | globenewswire.comSwitzerland's Canton of Ticino Implements BIO-key's Multi-Factor Authentication Solution in its Information Systems CenterApril 5, 2024 | uk.investing.comEarnings call: BIO-key anticipates growth and profitability in 2024April 4, 2024 | seekingalpha.comBIO-key International, Inc. (BKYI) Q4 2023 Earnings Call TranscriptApril 3, 2024 | finance.yahoo.comBIO-key International, Inc. (NASDAQ:BKYI) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.comIdentity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10am ETApril 1, 2024 | globenewswire.comIdentity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx.April 1, 2024 | markets.businessinsider.comBio-Key International earnings preview: what Wall Street is expectingMarch 27, 2024 | globenewswire.comIdentity and Access Management/Cybersecurity Solutions Provider BIO-key International Hosts Q4 Investor Call Tues., Apr. 2nd at 10am ETMarch 12, 2024 | finance.yahoo.comUPDATE - Humanity International Investments Announces Milestone Achievements in the Humanity Protocol InitiativeMarch 12, 2024 | globenewswire.comHumanity International Investments Hits Major Milestones in Digital Identity with the Humanity Protocol Initiative in Partnership with BIO-key InternationalMarch 12, 2024 | finance.yahoo.comHumanity International Investments Announces Milestone Achievements in the Humanity Protocol InitiativeFebruary 23, 2024 | finance.yahoo.comBIO-key International, Inc. (BKYI)February 22, 2024 | benzinga.comBIO-key Intl Stock (NASDAQ:BKYI), Quotes and News SummaryFebruary 22, 2024 | benzinga.comBIO-key Intl Stock (NASDAQ:BKYI) Insider TradesFebruary 22, 2024 | benzinga.comBIO-key Intl Stock (NASDAQ:BKYI) Dividends: History, Yield and DatesSee More Headlines Receive BKYI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today6/16/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:BKYI CUSIPN/A CIK1019034 Webwww.bio-key.com Phone(732) 359-1100Fax732-359-1101Employees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,520,000.00 Net Margins-114.24% Pretax Margin-111.62% Return on Equity-265.20% Return on Assets-98.69% Debt Debt-to-Equity Ratio0.18 Current Ratio0.82 Quick Ratio0.68 Sales & Book Value Annual Sales$7.75 million Price / Sales0.44 Cash FlowN/A Price / Cash FlowN/A Book Value$1.39 per share Price / Book1.34Miscellaneous Outstanding Shares1,814,000Free Float1,565,000Market Cap$3.37 million OptionableOptionable Beta0.46 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Michael W. DePasquale (Age 69)Chairman & CEO Comp: $296.83kMr. Kwok Fong Wong (Age 61)MD of Hong Kong & Vice-Chairman of the Board Ms. Mira K. LaCous (Age 62)Chief Technology Officer Comp: $224.3kMr. James David Sullivan (Age 57)Senior VP of Strategy & Compliance and Chief Legal Officer Comp: $367.49kMs. Cecilia C. Welch (Age 64)Chief Financial Officer Comp: $176.19kMr. Akintunde Carlton JejeManaging Director of AfricaMr. Alex RochaManaging Director of EMEAMr. Mark CochranPresident of PortalGuardMore ExecutivesKey CompetitorsWaveDancerNASDAQ:WAVDBanzai InternationalNASDAQ:BNZIGaxos.aiNASDAQ:GXAIInfobirdNASDAQ:IFBDSharpLink GamingNASDAQ:SBETView All CompetitorsInsidersJames David SullivanBought 1,111 shares on 11/30/2023Total: $3,399.66 ($3.06/share)James David SullivanBought 555 shares on 11/27/2023Total: $1,598.40 ($2.88/share)James David SullivanBought 1,648 shares on 11/24/2023Total: $4,746.24 ($2.88/share)James David SullivanBought 12,666 shares on 10/30/2023Total: $38,757.96 ($3.06/share)Michael W DepasqualeBought 9,166 shares on 10/30/2023Total: $28,047.96 ($3.06/share)View All Insider Transactions BKYI Stock Analysis - Frequently Asked Questions How have BKYI shares performed in 2024? BIO-key International's stock was trading at $3.00 at the start of the year. Since then, BKYI stock has decreased by 38.0% and is now trading at $1.86. View the best growth stocks for 2024 here. Are investors shorting BIO-key International? BIO-key International saw a decrease in short interest in the month of May. As of May 31st, there was short interest totaling 4,400 shares, a decrease of 37.1% from the May 15th total of 7,000 shares. Based on an average trading volume of 22,700 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.3% of the shares of the stock are sold short. View BIO-key International's Short Interest. When is BIO-key International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our BKYI earnings forecast. How were BIO-key International's earnings last quarter? BIO-key International, Inc. (NASDAQ:BKYI) announced its earnings results on Monday, November, 15th. The technology company reported ($2.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.98) by $0.36. The technology company had revenue of $1.30 million for the quarter. BIO-key International had a negative net margin of 114.24% and a negative trailing twelve-month return on equity of 265.20%. When did BIO-key International's stock split? BIO-key International's stock reverse split before market open on Thursday, December 21st 2023. The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. What guidance has BIO-key International issued on next quarter's earnings? BIO-key International updated its FY 2023 earnings guidance on Monday, April, 1st. The company provided earnings per share guidance of -11.450--11.450 for the period. The company issued revenue guidance of $9.1 million-$9.1 million, compared to the consensus revenue estimate of $10.0 million. What other stocks do shareholders of BIO-key International own? Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO). Who are BIO-key International's major shareholders? BIO-key International's stock is owned by a variety of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James David Sullivan, Michael W Depasquale and Michael W Depasquale. View institutional ownership trends. How do I buy shares of BIO-key International? Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BKYI) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIO-key International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIO-key International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.